Search Results - thomas+boyer

1 Results Sort By:
Endocrine Therapy Diagnostic for ER+ Breast Cancer
UT Health San Antonio seeks to partner with a diagnostic products company to develop and commercialize a clinical diagnostic with the potential to determine if a patient with estrogen receptor (ER) positive breast cancer is suitable for treatment with endocrine therapy (e.g., tamoxifen and/or the aromatase inhibitors anastrozole (Arimidex®), letrozole...
Published: 12/7/2023   |   Inventor(s): Amy Trauernicht, Thomas Boyer
Keywords(s): Biologics, Drugs
Category(s): Diagnostics > Assay, Clinical Specialty > Oncology, Clinical Specialty > Women's Health